Delivery Order SPE2DB22D3102-SPE2DB25FK9XD
Award Date
2/7/25
Potential Completion Date
2/10/25
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,274.35 firm fixed price delivery order covers the procurement of OLOPATADINE HCL 0.1% EYE DROPS 5ML, a specialty pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a...
This award is a delivery order contract valued at $2,129.24 for the supply of Olopatadine HCl 0.1% eye drops (5ml) to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of OLOPATADINE HCL 0.1% EYE DROPS 5ML. The firm-fixed-price delivery order, valued at $1,115.33, has a completion date of November 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical as a primary vehicle for providing a wide range of pharmaceutical products and medical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,125.53, is for the delivery of OLOPATADINE HCL 0.1% eye drops, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of April 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp is a Delivery Order valued at $1,009.00 for the procurement of Olopatadine HCl 0.1% eye drops in 5 ml containers. The contract has an ultimate completion date of October 31, 2023 and is a Firm Fixed Price agreement. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor for this award, which is not designated as a set-aside contract....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,310.09, is for the delivery of Olopatadine HCl 0.1% eye drops in 5ml vials. The contract is a delivery order type with a firm fixed price pricing structure, and the ultimate completion date is December 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $1,911.60, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4559605390 - Olopatadine HCL 0.1% Eye Drops 5ml. The contract has a firm fixed-price delivery order pricing type and an ultimate completion date of January 17, 2023. This award is a part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Olopatadine HCL 0.1% eye drops, a pharmaceutical product, with a ceiling value of $1,167.76 and a period of performance ending on May 5, 2023. The contract is a firm fixed-price delivery order and was not set aside for any specific business category. AmerisourceBergen Drug Corp holds...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,454.64 contract is for the supply of Olopatadine HCl 0.1% eye drops, a medication used to treat eye inflammation. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of OLOPATADINE HCL 0.1% eye drops, a pharmaceutical product, with a ceiling value of $2,987.69 and a completion date of January 14, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, that serves as a...